Previous studies have shown that plasma adiponectin levels are decreased in obesity, insulin resistance and type 2 diabetes [24, 25], Additionally, decreased plasma adiponectin levels have been associated with mild cognitive dysfunction [23]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.